The Latest Breaking News on Pharma

France’s Economy Minister has warned that the government could block the sale of a subsidiary of the French pharmaceutical company Sanofi to a US private equity firm if it cannot guarantee that its production of paracetamol, under the name Doliprane, remains in France.

The planned sale of France's best-selling medical drug to US investors has caused the government a splitting headache after an outcry against the project from politicians on all sides.

British drugmaker agrees payment to resolve 80,000 cases alleging cancers were linked to drug known generically as ranitidine

Despite growing demand for female health solutions, businesses are coming up against entrenched prejudice

Starboard has reached out to former Pfizer CEO Ian Read and ex-finance chief Frank D'Amelio, and both have expressed interest in supporting the activist investor's turnaround efforts, reports said.

The warning follows last week's U.S. Department of Justice (DOJ) indictment of illegal online pharmacies selling counterfeit prescription pills laced with fentanyl and methamphetamine to tens of thousands of people in the U.S., leading to at least nine deaths.

The healthcare industry is set for growth due to the growing demand for quality healthcare services and ongoing advancements in medical technology. Hence, investors might consider investing in healthcare stocks, Johnson & Johnson (JNJ), AbbVie (ABBV), and Thermo Fisher Scientific (TMO) for safe and steady growth. Read more….

The cuts will affect about 1% of its workforce.

The smell of chlorine pervades Conyers as residents say BioLab’s accident was a danger hiding in plain sight